NYSEAMERICAN:INFU

InfuSystem (INFU) Stock Forecast, Price & News

$9.80

+0.01 (+0.10%)

(As of 09/27/2023 ET)

Compare

Today's Range: $9.80
▼
$10.07
50-Day Range: N/A
52-Week Range: $6.10
▼
$11.44

Volume: 30,581 shs
Average Volume: 62,021 shs
Market Capitalization: $206.39 million

P/E Ratio: 326.78
Dividend Yield: N/A
Price Target: N/A

InfuSystem MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
1.61% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.20
Upright™ Environmental Score
News Sentiment: 0.37
Based on 5 Articles This Week
Insider Trading: Selling Shares
$864,215 Sold Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.89 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for InfuSystem.

4.0

Short Interest

Percentage of Shares Shorted
1.61% of the float of InfuSystem has been sold short.
Short Interest Ratio / Days to Cover
InfuSystem has a short interest ratio ("days to cover") of 5.8.
Change versus previous month
Short interest in InfuSystem has recently decreased by 15.16%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
InfuSystem does not currently pay a dividend.
Dividend Growth
InfuSystem does not have a long track record of dividend growth.

4.0

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
InfuSystem has received a 55.56% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Intravenous therapy equipment", "Medical dispensing pumps", and "Catheters" products. See details.
Environmental Sustainability
The Environmental Impact score for InfuSystem is -1.20.

1.9

News and Social Media Coverage

News Sentiment
InfuSystem has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for InfuSystem this week, compared to 0 articles on an average week.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, InfuSystem insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $864,215.00 in company stock.
Percentage Held by Insiders
18.50% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
65.03% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of InfuSystem is 328.44, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 118.23.
Price to Earnings Ratio vs. Sector
The P/E ratio of InfuSystem is 328.44, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 110.08.
Price to Book Value per Share Ratio
InfuSystem has a P/B Ratio of 4.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About InfuSystem (NYSEAMERICAN:INFU) Stock

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

INFU Price History

30 days | 90 days | 365 days | Advanced Chart

INFU Stock News Headlines

September 27, 2023 | americanbankingnews.com

InfuSystem (NYSEAMERICAN:INFU) Share Price Passes Above 200 Day Moving Average of $0.00

September 21, 2023 | markets.businessinsider.com

Lake Street Keeps Their Buy Rating on Accuray (ARAY)

September 27, 2023 | Stansberry Research (Ad)

Are "The Magnificent Seven" the Next Sears?

The former retail giant’s sales once accounted for 1% of the U.S. economy. Now it’s nearly extinct. Will the same happen to big tech? Learn more here.

September 21, 2023 | markets.businessinsider.com

Analysts Have Conflicting Sentiments on These Technology Companies: Societal CDMO (SCTL), AXT (AXTI) and comScore (SCOR)

September 18, 2023 | finance.yahoo.com

Elastomeric Infusion Pumps Market to grow by USD 800.97 million from 2022-2027 | North America to account for 44% of market growth - Technavio

September 11, 2023 | markets.businessinsider.com

Analysts Conflicted on These Technology Names: Bio-Techne (TECH) and Upstart Holdings (UPST)

September 5, 2023 | finance.yahoo.com

InfuSystem to Participate in Lake Street’s 7th Annual Best Ideas Growth (BIG7) Conference September 14, 2023

August 16, 2023 | uk.finance.yahoo.com

Q2 2023 Sanara Medtech Inc Earnings Call

September 27, 2023 | Stansberry Research (Ad)

Are "The Magnificent Seven" the Next Sears?

The former retail giant’s sales once accounted for 1% of the U.S. economy. Now it’s nearly extinct. Will the same happen to big tech? Learn more here.

August 3, 2023 | finance.yahoo.com

InfuSystem Reports Second Quarter 2023 Financial Results

July 31, 2023 | markets.businessinsider.com

Craig-Hallum Sticks to Its Buy Rating for InfuSystem Holdings, Inc. (INFU)

July 27, 2023 | finance.yahoo.com

InfuSystem to Report Second Quarter 2023 Financial Results on August 3, 2023

July 26, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: CareDx (CDNA), Merit Medical Systems (MMSI) and HealthStream (HSTM)

July 20, 2023 | finance.yahoo.com

Negative Pressure Wound Therapy Systems Global Market is Projected to Boost at a CAGR of ~5% by 2028 | DelveInsight

July 18, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Trulieve Cannabis (OtherTCNNF) and QuidelOrtho (QDEL)

July 12, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Apyx Medical (APYX) and Leap Therapeutics (LPTX)

July 6, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and iSpecimen (ISPC)

June 29, 2023 | markets.businessinsider.com

Analysts Offer Insights on Technology Companies: Societal CDMO (SCTL) and Evolv Technologies Holdings (EVLV)

June 27, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND) and REPRO-MED Systems (KRMD)

June 22, 2023 | msn.com

InfuSystem: Long-Term Business Economics Eroding Value, Reiterate Hold

June 20, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Repligen (RGEN)

May 5, 2023 | finance.yahoo.com

InfuSystem to Present at Sidoti Micro-Cap Virtual Conference on May 11, 2023

May 4, 2023 | finance.yahoo.com

InfuSystem Reports First Quarter 2023 Financial Results

May 3, 2023 | marketwatch.com

2023-2030 Large Volume Infusion Pumps Market Size (Growth and Outlook) includes Main Business Overview | with [90 Pages]

April 27, 2023 | finance.yahoo.com

InfuSystem to Report First Quarter 2023 Financial Results on May 4, 2023

April 25, 2023 | finance.yahoo.com

InfuSystem Announces Distribution Agreement with Genadyne for Negative Pressure Wound Therapy Systems

March 19, 2023 | finance.yahoo.com

InfuSystem Holdings, Inc. (AMEX:INFU) Q4 2022 Earnings Call Transcript

See More Headlines

Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

INFU Company Calendar

Last Earnings: 8/03/2023
Today: 9/27/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEAMERICAN
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSEAMERICAN:INFU
Previous Symbol: NYSE:INFU
CUSIP: N/A
CIK: 1337013
Web: ir.infusystem.com
Phone: (124) 291-1210
Fax: 800-455-4338
Employees: 420
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.03
Trailing P/E Ratio: 330.11
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $20,000.00
Net Margins: 0.56%
Pretax Margin: 0.93%
Return on Equity: 1.36%
Return on Assets: 0.66%

Debt

Debt-to-Equity Ratio: 0.72
Current Ratio: 2.22
Quick Ratio: 1.78

Sales & Book Value

Annual Sales: $109.91 million
Price / Sales: 1.90
Cash Flow: $0.65 per share
Price / Cash Flow: 15.20
Book Value: $2.32 per share
Price / Book: 4.27

Miscellaneous

Outstanding Shares: 21,060,000
Free Float: 17,160,000
Market Cap: $208.49 million
Optionable: Not Optionable
Beta: 1.25

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Richard A. DiIorio (Age 48)
CEO & Director
Comp: $806.26k

Ms. Carrie A. Lachance B.S.N. (Age 46)
M.B.A., R.N., Pres, COO & Director
Comp: $473.54k

Mr. Barry G. Steele (Age 52)
Exec. VP & CFO

Mr. Addam Chupa (Age 44)
Exec. VP & Chief Information Officer

Jeanie Latz
Corp. Sec.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

INFU Stock - Frequently Asked Questions

How have INFU shares performed in 2023?: InfuSystem's stock was trading at $9.30 on January 1st, 2023. Since then, INFU stock has increased by 6.5% and is now trading at $9.90.
View the best growth stocks for 2023 here.
Are investors shorting InfuSystem?: InfuSystem saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 296,600 shares, a decline of 15.2% from the August 31st total of 349,600 shares. Based on an average daily volume of 50,800 shares, the short-interest ratio is currently 5.8 days. Currently, 1.6% of the shares of the stock are short sold.
View InfuSystem's Short Interest.
How were InfuSystem's earnings last quarter?: InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) released its earnings results on Thursday, August, 3rd. The medical instruments supplier reported $0.02 earnings per share for the quarter. The medical instruments supplier had revenue of $31.74 million for the quarter. InfuSystem had a trailing twelve-month return on equity of 1.36% and a net margin of 0.56%.
What guidance has InfuSystem issued on next quarter's earnings?: InfuSystem updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $120.91M-, compared to the consensus revenue estimate of $120.00 million.
What other stocks do shareholders of InfuSystem own?: Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Second Sight Medical Products (EYES), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS).
What is InfuSystem's stock symbol?: InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

Who are InfuSystem's major shareholders?: InfuSystem's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.92%), Meros Investment Management LP (4.23%), Ranger Investment Management L.P. (3.31%), Wasatch Advisors LP (3.30%), Cove Street Capital LLC (2.23%) and Dimensional Fund Advisors LP (1.96%). Insiders that own company stock include Blueline Capital Partners Ii,, Carrie Lachance, Christopher R Sansone, Gregg Owen Lehman, Jeannine Sheehan, Kevin Whitman, Meridian Ohc Partners, Lp, Paul Andrew Gendron, R Rimmy Malhotra, Richard Dilorio and Thomas Mark Ruiz.
View institutional ownership trends.
How do I buy shares of InfuSystem?: Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is InfuSystem's stock price today?: One share of INFU stock can currently be purchased for approximately $9.90.
How much money does InfuSystem make?: InfuSystem (NYSEAMERICAN:INFU) has a market capitalization of $208.49 million and generates $109.91 million in revenue each year. The medical instruments supplier earns $20,000.00 in net income (profit) each year or $0.03 on an earnings per share basis.
How many employees does InfuSystem have?: The company employs 420 workers across the globe.
How can I contact InfuSystem?: InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The official website for the company is ir.infusystem.com. The medical instruments supplier can be reached via phone at (124) 291-1210 or via fax at 800-455-4338.

This page (NYSEAMERICAN:INFU) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial